- Home
- BBGI vs NERV Comparison
BBGI vs NERV Comparison
Compare BBGI & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- NERV
- Stock Information
- Founded
- BBGI 1961
- NERV 2007
- Country
- BBGI United States
- NERV United States
- Employees
- BBGI N/A
- NERV N/A
- Industry
- BBGI Broadcasting
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- NERV Health Care
- Exchange
- BBGI Nasdaq
- NERV Nasdaq
- Market Cap
- BBGI 13.2M
- NERV 15.5M
- IPO Year
- BBGI 2000
- NERV 2014
- Fundamental
- Price
- BBGI $7.81
- NERV $1.82
- Analyst Decision
- BBGI
- NERV Hold
- Analyst Count
- BBGI 0
- NERV 1
- Target Price
- BBGI N/A
- NERV $5.00
- AVG Volume (30 Days)
- BBGI 3.1K
- NERV 77.1K
- Earning Date
- BBGI 03-04-2025
- NERV 03-04-2025
- Dividend Yield
- BBGI N/A
- NERV N/A
- EPS Growth
- BBGI N/A
- NERV N/A
- EPS
- BBGI 1.69
- NERV N/A
- Revenue
- BBGI $238,754,777.00
- NERV N/A
- Revenue This Year
- BBGI $2.55
- NERV N/A
- Revenue Next Year
- BBGI N/A
- NERV N/A
- P/E Ratio
- BBGI $4.63
- NERV N/A
- Revenue Growth
- BBGI N/A
- NERV N/A
- 52 Week Low
- BBGI $7.60
- NERV $1.77
- 52 Week High
- BBGI $18.40
- NERV $7.53
- Technical
- Relative Strength Index (RSI)
- BBGI 40.68
- NERV 34.70
- Support Level
- BBGI $7.77
- NERV $1.77
- Resistance Level
- BBGI $8.10
- NERV $2.05
- Average True Range (ATR)
- BBGI 0.25
- NERV 0.16
- MACD
- BBGI 0.03
- NERV -0.04
- Stochastic Oscillator
- BBGI 13.16
- NERV 6.41
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The Company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. The Company owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The Company currently operates three operating segments Audio, Digital and esports.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.